|
|
Influence of bone marrow mesenchymal stem cells on lung ischemiareperfusion injury in mice |
SUN Chang-rong1,2 HOU Nian-guo1 LI Hui1 SHUAI Xun-jun1 SUN Ming-jie1 TANG Yu-ru1 XU Tang-wen1,2 AI Deng-bin1▲ |
1.Department of Anesthesiology,Weifang Medical College,Shandong Province,Weifang 261053,China;
2.Department of Anesthesiology,Research Center of Clinical Anesthesiology of Qingdao City,Qingdao Municipal Hospital,Shandong Province,Qingdao 266011,China |
|
|
Abstract ObjectiveTo investigate the influence of bone marrow mesenchymal stem cells(BMSCs)on lung ischemiareperfusion injury(LIRI)in mice.MethodsBMSCs from rats were isolated,cultured and purified by the whole bone marrow acherence method.LIRI was produced by occlusion of the left hilum of lungs for 60 min followed by 240 min reperfusion.70 mice were randomly divided into 7 groups(n=10),included the sham operation group(the Sham group),the ischemia-reperfusion group(the I/R group),the BMSCs 1 group(tail vein injections of 1×106BMSCs),the BMSCs 2 group(tail vein injections of 2×106BMSCs),the BMSCs 5 group(tail vein injection of 5×106BMSCs),the BMSCs 10 group(tail vein injection of 10×106BMSCs),the BMSCs it group(endotracheal injection of 5×106BMSCs).At the end of reperfusion,blood samples were obtained for blood gas analysis and PaO2/FiO2was calculated.Then,the animals were sacrificed and lung tissues were immediately removed for determination of superoxide dismutase(SOD),tumor necrosis factor-α(TNF-α),interleukin-8 (IL-8),and myeloperoxidase (MPO)and for microscopic examination of the pathological changes of lungs which were scored.ResultsCompared with Sham group,PaO2/FiO2was significantly decreased,the pathological scores and the levels of TNF-α,IL-8,and MPO were increased,and SOD activity was decreased in I/R,BMSCs 1,BMSCs 2,BMSCs 5,BMSCs 10,BMSCs it group,the difference was statistically significant (P<0.05).Compared with I/R group,PaO2/FiO2was significantly increased,the pathological scores and the levels of TNF-α,IL-8,and MPO in lung tissues were decreased,and SOD activity was increased in BMSCs 1,BMSCs 2,BMSCs 5,BMSCs 10,BMSCs it group,the difference was statistically significant(P<0.05).The most obvious group is BMSCs 10,the difference was statistically significant(P<0.05).There is no obvious difference between endotracheal injection and intravascular injection with the same concentration of BMSCs,the difference was not statistically significant(P>0.05).ConclusionBMCS can alleviate LIRI in mice,and the responsible mechanism is related to inhibition of inflammatory responses.The lung protective effect is dose dependent.There is no significant difference between endotracheal injection and intravascular injection with the same concentration of BMSCs.
|
|
|
|
|
[1] |
Dong Y,Undyala VV,Gottlieb RA,et al.Review:autophagy:definition,molecular machinery,and potential role in myocardial ischemia-reperfusion injury[J].J Cardiovascular Pharmacol Therapeutics,2010,15(3):220-230.
|
[2] |
de Perrot M,Liu M,Waddell TK,et al.Ischemia-reperfusion-induced lung injury[J].Am J Respir Crit Med,2003,167(4):490-511.
|
[3] |
徐炎.骨髓间充质干细胞静脉注射移植对脑缺血大鼠脑内神经细胞增殖的影响[D].重庆:第三军医大学,2007.
|
[4] |
张红珊,方建培.骨髓间充质干细胞修复肺损伤研究进展[J].中国呼吸与危重监护杂志,2011,10(5):505-508.
|
[5] |
徐婷.3.0T MRI活体示踪BMSCs移植修复肾脏缺血再灌注损伤[D].太原:山西医科大学,2014.
|
[6] |
Hu H,Wang G.Bone marrow mesenchymal stem cell protect against renal ischemia reperfusion injury through paracrine mechanism[J].J Clin Rehabilitative Tissue Engineering Res,2011,15(32):5995-5998.
|
[7] |
Zhuang S,Liu Y,Chen K,et al.Suitable conditions for the isolationpurificationandcultureofratbonemarrowmesenchymal stem cells in vitro[J].J Clin Rehabilitative Tissue Engineering Res,2007,11(20):3886-3891.
|
[8] |
Altemeier WA,Conrad LW,Ana VG,et al.Ischemia-reperfusion lung injury is attenuated in MyD88-deficient mice[J].PloS One,2013,8(10):e77123.
|
[9] |
Kozian A,Schiling T,Freden F,et al.One-lung ventilation induces hyperperfusion and alveolar damage in the ventilated lung:an experimental study[J].Br J Anaesth,2008,100(4):549-559.
|
[10] |
聂君,李劲松,王建军,等.肺缺血再灌注损伤机制和防治进展[J].国际移植与血液净化,2007,5(3):20-26.
|
[11] |
艾娜.TSP-1及其受体CD47在大鼠肾缺血再灌注损伤大鼠模型中的作用及机制初步探讨[D].泸州:泸州医学院,2014.
|
[12] |
蒋冠军.Nesfatin-1预处理在大鼠肾缺血再灌注损伤模型中的保护作用及相关机制的研究[D].武汉:武汉大学,2016.
|
[13] |
Esme H,Fidan H,Koken T,et al.Effect of lung ischemiareperfusion on oxidative stress parameters of remote tissues[J].Eur J cardiothorac Surg,2006,29(3):294-298.
|
[14] |
Den Hengest WA,Gielies JF,Lin JY,et al.Lung ischemiareperfusion injury:a molecular and clinical view on a complex pathophysiological process[J].Am Physiol Heart Circ Physiol,2010,299(5):H1283-H1299.
|
[15] |
Kotloff RM,Thabut G.Lung transplantation[J].Am J Respir Crit Med,2011,184(2):159-171.
|
[16] |
张艳芳,王琦,杨廷桐.白介素-1、8、10与药物干预对大鼠心肌缺血再灌注损伤的影响[J].新乡医学院学报,2006,23(6):572-574.
|
[17] |
张震宇,刘伟,杨卫良,等.大鼠骨骼肌缺血再灌注损伤的细胞凋亡及相关基因表达[J].中华创伤骨科杂志,2007,9(5):452-455.
|
[18] |
段若望,李明星,宋炯,等.不同血液PH值对大鼠肺移植时缺血再灌注损伤的影响[J].中华麻醉学杂志,2010,30(6):685-687.
|
[19] |
Bosmann M,Ward PA.Protein-based therapies for acute lung injury:targeting neutrophil extracellular traps[J].Expert Opin Ther Targets,2014,18(6):703-714.
|
[20] |
Maxey TS,Enelow R,Gaston B,et al.Tumor necrosis factor-alpha from resident lung cells is a key initiating factor in pulmonary ischemia-reperfusion injury[J].J Thorac Cardiovas Surg,2004,127(2):541-547.
|
[21] |
李瑶,吕德官,陈临溪,等.IL-8及其受体药物与疾病的研究进展[J].中国药理学通报,2014,30(3):310-313.
|
|
|
|